Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2055094 | International Journal of Medical Microbiology | 2006 | 8 Pages |
Abstract
Borrelia burgdorferi, a spirochaete transmitted to human hosts during feeding of infected Ixodes ticks, is the causative agent of Lyme disease, the most frequent vector-borne disease in Eurasia and North America. Sporadically Lyme disease develops into a chronic, multisystemic disorder. Serum-resistant B. burgdorferi strains bind complement factor H (FH) and FH-like protein 1 (FHL-1) on the spirochaete surface. This binding is dependent on the expression of proteins termed complement-regulator acquiring surface proteins (CRASPs). The atomic structure of BbCRASP-1, the key FHL-1/FH-binding protein of B. burgdorferi, has recently been determined. Our analysis indicates that its protein topology apparently evolved to provide a high affinity interaction site for FH/FHL-1 and leads to an atomic-level hypothesis for the functioning of BbCRASP-1. This work demonstrates that pathogens interact with complement regulators in ways that are distinct from the mechanisms used by the host and are thus obvious targets for drug design.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Frank S. Cordes, Peter Kraiczy, Pietro Roversi, Markus M. Simon, Volker Brade, Oliver Jahraus, Russell Wallis, Leo Goodstadt, Chris P. Ponting, Christine Skerka, Peter F. Zipfel, Reinhard Wallich, Susan M. Lea,